1. Home
  2. EB vs IVVD Comparison

EB vs IVVD Comparison

Compare EB & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eventbrite Inc.

EB

Eventbrite Inc.

HOLD

Current Price

$4.51

Market Cap

442.9M

Sector

Technology

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

N/A

Current Price

$1.80

Market Cap

437.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EB
IVVD
Founded
2003
2020
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
442.9M
437.1M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
EB
IVVD
Price
$4.51
$1.80
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$5.00
$8.75
AVG Volume (30 Days)
1.8M
1.6M
Earning Date
01-01-0001
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
34.62
79.02
EPS
N/A
N/A
Revenue
$326,134,000.00
$53,426,000.00
Revenue This Year
N/A
$143.48
Revenue Next Year
$4.70
$25.40
P/E Ratio
N/A
N/A
Revenue Growth
24.99
110.47
52 Week Low
$1.81
$0.46
52 Week High
$4.51
$3.07

Technical Indicators

Market Signals
Indicator
EB
IVVD
Relative Strength Index (RSI) 77.04 50.50
Support Level $4.43 $1.41
Resistance Level N/A $2.01
Average True Range (ATR) 0.02 0.11
MACD 0.00 0.04
Stochastic Oscillator 100.00 56.18

Price Performance

Historical Comparison
EB
IVVD

About EB Eventbrite Inc.

Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. The company's two-sided marketplace connects creators and consumers every month to share their passions, artistry, and causes through live experiences. Creators use its self-service ticketing and marketing tools to plan, promote, and sell tickets to their events, and event seekers use its website and mobile application to discover and purchase tickets to experiences. Geographically, it generates maximum revenue from the United States. The company generates revenues principally from service fees and payment processing fees from the sale of paid tickets on its platform.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: